|
|
||||||||
The Journal of Immunology, Vol 153, Issue 10 4583-4587, Copyright © 1994 by American Association of Immunologists
ARTICLES |
MH Beaman, CA Hunter and JS Remington
Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, 94301.
Toxoplasma gondii is a major pathogen of immunocompromised hosts, and one defense mechanism against the parasite is activation of macrophages (M phi) for toxoplasmacidal activity by IFN-gamma after triggering by TNF-alpha. IL-6, IFN-gamma, and TNF-alpha are cytokines involved in inflammatory responses and are induced by T. gondii infection. We studied the interaction of these three cytokines using an in vitro model of T. gondii infection. Pretreatment (but not post-treatment) of unelicited murine peritoneal M phi with IL-6 enhanced T. gondii replication in a dose-dependent manner. Pretreatment with IFN-gamma resulted in active killing of parasites whereas the addition of IL-6 to IFN-gamma pretreatment resulted in a reversal of IFN-gamma-mediated toxoplasmacidal activity. Combining TNF-alpha with IL-6 and IFN-gamma pretreatment resulted in restoration of toxoplasmacidal activity. Addition of a polyclonal anti-TNF-alpha Ab to IL-6 and IFN-gamma pretreatment resulted in enhancement in the IL-6-mediated impairment of IFN-gamma function. These data taken together suggest that IL-6 enhances intracellular replication of T. gondii and reverses IFN-gamma mediated activation of murine peritoneal M phi, and that certain of the interactions between these two cytokines may be at the level of TNF- alpha triggering.
This article has been cited by other articles:
![]() |
H. W. Murray Accelerated Control of Visceral Leishmania donovani Infection in Interleukin-6-Deficient Mice Infect. Immun., September 1, 2008; 76(9): 4088 - 4091. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Barrionuevo, J. Cassataro, M. V. Delpino, A. Zwerdling, K. A. Pasquevich, C. G. Samartino, J. C. Wallach, C. A. Fossati, and G. H. Giambartolomei Brucella abortus Inhibits Major Histocompatibility Complex Class II Expression and Antigen Processing through Interleukin-6 Secretion via Toll-Like Receptor 2 Infect. Immun., January 1, 2008; 76(1): 250 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Nagabhushanam, A. Solache, L.-M. Ting, C. J. Escaron, J. Y. Zhang, and J. D. Ernst Innate Inhibition of Adaptive Immunity: Mycobacterium tuberculosis-Induced IL-6 Inhibits Macrophage Responses to IFN-{gamma} J. Immunol., November 1, 2003; 171(9): 4750 - 4757. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Lyons, J. P. Anthony, D. J. P. Ferguson, N. Byrne, J. Alexander, F. Roberts, and C. W. Roberts Immunological Studies of Chronic Ocular Toxoplasmosis: Up-Regulation of Major Histocompatibility Complex Class I and Transforming Growth Factor {beta} and a Protective Role for Interleukin-6 Infect. Immun., April 1, 2001; 69(4): 2589 - 2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Halonen, F.-C. Chiu, and L. M. Weiss Effect of Cytokines on Growth of Toxoplasma gondii in Murine Astrocytes Infect. Immun., October 1, 1998; 66(10): 4989 - 4993. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |